Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-18T21:53:34.315Z Has data issue: false hasContentIssue false

10 - Biomaterials and Multifunctional Biocompatible Ultrananocrystalline Diamond (UNCD™) Technologies Transfer Pathway

From the Laboratory to the Market for Medical Devices and Prostheses

Published online by Cambridge University Press:  08 July 2022

Orlando Auciello
Affiliation:
University of Texas, Dallas
Get access

Summary

This chapter focus on a description of pathways undertaken to transfer the UNCD film technology from the laboratory into the market, through Original Biomedical Implants (OBI-USA) and OBI-México, founded by O. Auciello and colleagues. Topics discussed in this chapter include: 1) Summary of regulatory pathways in different regions of the worldfor approval of medical devices and prostheses; 2) description of pathway to bring to the market a UNCD-coated microchip (artificial retina) implantable inside the eye to restore partial vision to blind people), 2) description of the process to bring to the market a new generation of long life superior performance UNCD-coated prostheses (artificial hips, knees, dental implants, and more); 3) description of pathway to bring into the market a novel retina reattachment process using combined UNCD-coated magnet outside the eye and injection of super-paramagnetic nanoparticles inside the eye, pushing the retina backon to the inner eye’ layer, when attracted by the magnetic field created by the external magnet.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2022

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Woo, R., Jenkins, D. D., and Greco, R. S., “Biomaterials, and historical overview and current directions,” in Nanotechnology in Nanoscale Technology in Biological Systems, Greco, R., Ed. Boca Raton, FL: Taylor and Francis, 2005.Google Scholar
Williams, D. F., “On the nature of biomaterials,” Biomaterials, vol. 30, p. 5897, 2009.Google Scholar
Constantz, B., “Crossing the chasm: adoption of new medical device nanotechnology,” in Nanoscale Technology in Biological Systems, Greco, R., Ed. Boca Raton, FL: CRC Press, 2005.Google Scholar
Rice, T. W., “The historical, ethical and legal background of human subjects’ research,” Respir Care, vol. 53 (10), p. 1325, 2008.Google ScholarPubMed
World Medical Association, Helsinki Declaration. www.wma.net.Google Scholar
European Commission Enterprise and Industry. Homepage. http://ec.europa.eu/atoz_en.htm.Google Scholar
Ministry of Health Labor and Welfare, Japan. Homepage. www.mhlw.go.jp/english.Google Scholar
Pharmaceutical and Medical Device Agency, Japan. Homepage. www.pmda.go.jp/english/index.html.Google Scholar
Medicines and Health Care Products Regulatory Agency, UK. Homepage. www.mhra.gov.uk/index.htm.Google Scholar
Gurman, P., Rabinovitz-Harison, O., and Hunter, T. B., “Regulatory challenges in biomaterials: focus on medical devices,” in Biomaterials Science: A Clinical and Engineering Approach. Boca Raton, FL: CRC Press, 2012.Google Scholar
FDA. United States FDA Medical Devices Control and Regulation Handbook, 4th ed. Washington, DC: International Publisher Publications, 2010.Google Scholar
Feldman, M. D., Petersen, A., Karliner, L., et al., “Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment,” J. Gen. Inter. Med., vol. 23 (suppl. 1), p. 57, 2008.CrossRefGoogle ScholarPubMed
Dhruva, S. S., Bero, L. A., and Redberg, R. F., “Strength of the evidence examined by the FDA in premarket approval of cardiovascular devices,” JAMA, vol. 302 (24), p. 2679, 2009.CrossRefGoogle ScholarPubMed
Brown, S. L., Bright, R. A., and Travis, D. R., “Medical device epidemiology and surveillance: patient safety is the bottom line,” Expert Rev. Med. Dev. vol. 1 (1), p. 1, 2004.CrossRefGoogle ScholarPubMed
Medical Device Regulations, “Global overview and guiding principles: World Health Organization Report,” 2003. www.who.int/whr/2003/en/whr03_en.pdf.Google Scholar
FDA, “Medical device exemptions 510(k) and GMP requirement.” www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpcd/315.cfm?GMPPart=878#start.Google Scholar
Humayun, M., “Interim results from the international trial of Second Sight’s visual prosthesis,Ophthalmology, vol. 119, p. 779, 2012.CrossRefGoogle ScholarPubMed
Second Sight. Homepage. www.secondsight.com.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×